Quest PharmaTech Inc. (QPTFF)
OTCMKTS · Delayed Price · Currency is USD
0.0133
-0.0017 (-11.33%)
At close: Jul 15, 2024
Quest PharmaTech Market Cap
Quest PharmaTech has a market cap or net worth of $4.88 million as of August 25, 2025. Its market cap has decreased by -52.42% in one year.
Market Cap
4.88M
Enterprise Value
5.56M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since June 18, 1999, Quest PharmaTech's market cap has decreased from 6.09M to 4.88M, a decrease of -19.74%. That is a compound annual growth rate of -0.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2025 | 4.88M | 38.53% |
| Dec 30, 2024 | 3.53M | -49.98% |
| Dec 28, 2023 | 7.05M | -13.23% |
| Dec 30, 2022 | 8.12M | -35.69% |
| Dec 31, 2021 | 12.63M | -58.29% |
| Dec 31, 2020 | 30.28M | 81.67% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 632.06M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |